FIELD: medicine, pharmacy. SUBSTANCE: pharmaceutical preparation containing growth hormone and histidine or histidine derivative as an addition or a buffer substance shows very high resistance to deamidination, oxidation and peptide bonds cleavage. Product stability provides a possibility of its storage and transport in a lyophilized state or in the form of dissolved or again dissolved preparation at environment temperature. Crystallization of growth hormone in the presence of histidine or its derivative provides the increased crystals yield. EFFECT: increased yield, improved purity of growth hormone. 14 cl, 12 tbl, 2 dwg, 11 ex
Title | Year | Author | Number |
---|---|---|---|
GROWTH HORMONE PHARMACEUTICAL PREPARATION AND ITS STABILIZING AGENT | 1994 |
|
RU2098130C1 |
METHOD OF PREPARING GROWTH HORMONE OR GROWTH HORMONE DERIVATIVE CRYSTALS, HUMAN GROWTH HORMONE OR HUMAN DERIVATIVE GROWTH HORMONE CRYSTALS AND PHARMACEUTICAL PREPARATION | 1991 |
|
RU2108341C1 |
PHARMACEUTICAL COMPOSITION COMPRISING GROWTH HORMONE, AMINO ACID AND NON-IONIC DETERGENT | 1997 |
|
RU2236250C2 |
LIPOPHILIC DERIVATIVES OF PEPTIDE HORMONES | 1996 |
|
RU2171261C2 |
CARBOHYDRATE-CONTAINING INSULIN PREPARATIONS | 1997 |
|
RU2204411C2 |
GROWTH HORMONE-CONTAINING COMPOSITIONS | 2000 |
|
RU2298415C2 |
COMPOUNDS PROMOTING GROWTH HORMONE RELEASE | 1994 |
|
RU2167881C2 |
HUMAN GROWTH FACTOR HORMONE CRYSTALS AND METHODS OF THEIR OBTAINMENT | 2003 |
|
RU2357750C2 |
ZINC-FREE INSULIN CRYSTAL FOR APPLICATION IN PULMONARY COMPOSITIONS | 1998 |
|
RU2198181C2 |
INSULIN PREPARATION CONTAINING NACL, PARENTERAL FINISHED FORM, METHOD FOR INCREASING CHEMICAL STABILITY OF INSULIN PREPARATION | 1997 |
|
RU2182015C2 |
Authors
Dates
1998-11-27—Published
1992-12-16—Filed